A hybrid protein cocrystal of insulin and a lipophilically modified derivative provides smoother and longer lasting control of glucose levels.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Pembrolizumab microgravity crystallization experimentation
npj Microgravity Open Access 02 December 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Brader, M.L. et al. Nat. Biotechnol. 20, 800–804 (2002).
Avgerinos, G.C. et al. Semin. Thrombosis Hemostasis 27, 357–372 (2001).
Tracy, M.A. Biotechnol. Prog. 14, 108–115 (1998).
Hagedorn, H.C., Jensen, B.N., Krarup, N.B. & Wodstrup, I. JAMA 106, 177–180 (1936).
Gietz, U. et al. Eur. J. Pharm. Sci. 11, 33–41 (2000).
Jen, A. et al. J. Control. Release 78, 25–34 (2002).
Jen, A. & Merkle, H.P. Pharm. Res. 18, 1483–1488 (2001).
Mittl, P.R.E. et al. Protein Sci. 5, 1261–1271 (1996).
Anonymous. Nat. Biotechnol. 16, 115 (1998).
Margolin, A.L., Persichetti, R.A., St. Clair, N.L. & Khalaf, N.K. Controlled dissolution crosslinked protein crystals. US patent 6,140,475 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Merkle, H., Jen, A. A crystal clear solution for insulin delivery. Nat Biotechnol 20, 789–790 (2002). https://doi.org/10.1038/nbt0802-789
Issue Date:
DOI: https://doi.org/10.1038/nbt0802-789
This article is cited by
-
Pembrolizumab microgravity crystallization experimentation
npj Microgravity (2019)
-
Large-scale crystallization of proteins for purification and formulation
Bioprocess and Biosystems Engineering (2015)
-
Novel Long-Acting Crystal Formulation of Human Growth Hormone
Pharmaceutical Research (2005)